FGFR2 and gastric cancer: These compounds are also known to have a potential kinase inhibitory effect on FGFRs (Takeda et al, 2007; Turner et al, 2010), indicating that the development of these multi-kinase inhibitors may be a promising approach to the treatment of FGFR2-amplified gastric cancer.